New ECG technology aims to spot hidden heart disease before the first heart attack

NCT ID NCT02814396

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study evaluates a new multichannel ECG system designed to detect early signs of cardiovascular disease (CVD) in people who may have no symptoms yet. The system uses advanced algorithms to analyze electrical signals from the heart, looking for subtle abnormalities that could indicate future heart problems. Researchers aim to see if this portable device can diagnose CVD with good accuracy, potentially allowing earlier intervention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a multichannel ECG analytic system with new algorithms
What this could lead to
If successful, this could enable earlier, portable detection of heart disease, potentially preventing heart attacks and other cardiovascular events.
What could go wrong
This is an early-stage diagnostic study, and the new system may not prove accurate enough for widespread use. Results need validation in larger, diverse populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NTUH

    RECRUITING

    Taipei, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.